250 related articles for article (PubMed ID: 24801170)
1. Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.
Haga H; Yan I; Takahashi K; Wood J; Patel T
Gene Expr; 2014; 16(2):93-9. PubMed ID: 24801170
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of cholangiocarcinoma carcinogenesis.
Maemura K; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):754-60. PubMed ID: 24895231
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs.
Kawahigashi Y; Mishima T; Mizuguchi Y; Arima Y; Yokomuro S; Kanda T; Ishibashi O; Yoshida H; Tajiri T; Takizawa T
J Nippon Med Sch; 2009 Aug; 76(4):188-97. PubMed ID: 19755794
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
Braconi C; Patel T
Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
[TBL] [Abstract][Full Text] [Related]
5. The role of microRNAs in intrahepatic cholangiocarcinoma.
Li Z; Shen J; Chan MT; Wu WK
J Cell Mol Med; 2017 Jan; 21(1):177-184. PubMed ID: 27619971
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation in the carcinogenesis of cholangiocarcinoma.
Chiang NJ; Shan YS; Hung WC; Chen LT
Int J Biochem Cell Biol; 2015 Oct; 67():110-4. PubMed ID: 26100596
[TBL] [Abstract][Full Text] [Related]
7. Genetic and molecular abnormalities in cholangiocarcinogenesis.
Hassid VJ; Orlando FA; Awad ZT; Tan D; Khoury T; Ahmed BH; Alrawi SJ
Anticancer Res; 2009 Apr; 29(4):1151-6. PubMed ID: 19414358
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific marker genes for intrahepatic cholangiocarcinoma: utility and mechanistic insight.
Blechacz B; Gores GJ
J Hepatol; 2008 Aug; 49(2):160-2. PubMed ID: 18538440
[No Abstract] [Full Text] [Related]
9. Prognostic value of microRNA-21 in intra- and extrahepatic cholangiocarcinoma after radical resection: cohort study.
Boyd LNC; Ali M; Comandatore A; Brandi G; Tavolari S; Gaeta R; Meijer LL; Le Large TYS; Riefolo M; Vasuri F; Morelli L; van Laarhoven HWM; Giovannetti E; Kazemier G; Garajová I
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38637298
[No Abstract] [Full Text] [Related]
10. Molecular pathogenesis of cholangiocarcinoma.
Rizvi S; Gores GJ
Dig Dis; 2014; 32(5):564-9. PubMed ID: 25034289
[TBL] [Abstract][Full Text] [Related]
11. Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini.
Plieskatt JL; Rinaldi G; Feng Y; Peng J; Yonglitthipagon P; Easley S; Laha T; Pairojkul C; Bhudhisawasdi V; Sripa B; Brindley PJ; Mulvenna JP; Bethony JM
J Hepatol; 2014 Oct; 61(4):850-8. PubMed ID: 25017828
[TBL] [Abstract][Full Text] [Related]
12. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
13. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of microRNA-203 in cholangiocarcinoma.
Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
[TBL] [Abstract][Full Text] [Related]
15. Correlation between KRAS gene mutations and linicopathological features of patients with intrahepatic cholangiocarcinoma.
Wang J; Xu MX; Wang LQ; Li HY; Wang ZL; Li LJ
J Biol Regul Homeost Agents; 2019; 33(5):1551-1557. PubMed ID: 31635679
[No Abstract] [Full Text] [Related]
16. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
17. Cholangiopathies and the noncoding revolution.
Gradilone S; Brunetti-Pierri N; Piccolo P
Curr Opin Gastroenterol; 2022 Mar; 38(2):128-135. PubMed ID: 35098934
[TBL] [Abstract][Full Text] [Related]
18. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
Peng F; Jiang J; Yu Y; Tian R; Guo X; Li X; Shen M; Xu M; Zhu F; Shi C; Hu J; Wang M; Qin R
Br J Cancer; 2013 Dec; 109(12):3092-104. PubMed ID: 24169343
[TBL] [Abstract][Full Text] [Related]
19. ABCB4/MDR3 gene mutations and cholangiocarcinomas.
Tougeron D; Fotsing G; Barbu V; Beauchant M
J Hepatol; 2012 Aug; 57(2):467-8. PubMed ID: 22387667
[No Abstract] [Full Text] [Related]
20. Identifying survival-associated ceRNA clusters in cholangiocarcinoma.
Wan M; Zhang FM; Li ZL; Kang PC; Jiang PM; Wang YM; Wang ZD; Zhong XY; Li CL; Wang H; Zhao SY; Cui YF
Oncol Rep; 2016 Sep; 36(3):1542-50. PubMed ID: 27432084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
